Heidelberg Pharma Valuation
| HPHA Stock | EUR 2.33 0.07 2.92% |
Based on Macroaxis valuation methodology, the firm appears to be overvalued. Heidelberg Pharma retains a regular Real Value of €1.96 per share. The prevalent price of the firm is €2.33. Our model calculates the value of Heidelberg Pharma from evaluating the firm fundamentals such as Price To Book of 24.79 X, current valuation of 194.72 M, and EBITDA of (24.84 M) as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Heidelberg Pharma's price fluctuation is risky at this time. Calculation of the real value of Heidelberg Pharma is based on 3 months time horizon. Increasing Heidelberg Pharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Heidelberg Pharma's intrinsic value may or may not be the same as its current market price of 2.33, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.33 | Real 1.96 | Hype 2.33 | Naive 2.48 |
The intrinsic value of Heidelberg Pharma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Heidelberg Pharma's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Heidelberg Pharma AG helps investors to forecast how Heidelberg stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Heidelberg Pharma more accurately as focusing exclusively on Heidelberg Pharma's fundamentals will not take into account other important factors: Heidelberg Pharma Total Value Analysis
Heidelberg Pharma AG is currently anticipated to have takeover price of 194.72 M with market capitalization of 173.26 M, debt of , and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Heidelberg Pharma fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
194.72 M | 173.26 M |
Heidelberg Pharma Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The newest return on assets of Heidelberg implies not a very effective usage of assets in January.Heidelberg Pharma Profitability Analysis
The company reported the revenue of 1.75 M. Net Loss for the year was (26.14 M) with profit before overhead, payroll, taxes, and interest of 0.About Heidelberg Pharma Valuation
The stock valuation mechanism determines Heidelberg Pharma's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Heidelberg Pharma based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Heidelberg Pharma. We calculate exposure to Heidelberg Pharma's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Heidelberg Pharma's related companies.8 Steps to conduct Heidelberg Pharma's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Heidelberg Pharma's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Heidelberg Pharma's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Heidelberg Pharma's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Heidelberg Pharma's revenue streams: Identify Heidelberg Pharma's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Heidelberg Pharma's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Heidelberg Pharma's growth potential: Evaluate Heidelberg Pharma's management, business model, and growth potential.
- Determine Heidelberg Pharma's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Heidelberg Pharma's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Heidelberg Stock Analysis
When running Heidelberg Pharma's price analysis, check to measure Heidelberg Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heidelberg Pharma is operating at the current time. Most of Heidelberg Pharma's value examination focuses on studying past and present price action to predict the probability of Heidelberg Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heidelberg Pharma's price. Additionally, you may evaluate how the addition of Heidelberg Pharma to your portfolios can decrease your overall portfolio volatility.